President Trump on Friday signed executive orders that revive several of the administration's previous drug pricing ideas — including attempts to require Medicare to pay no more for drugs than the lowest prices paid by other countries and changing how drug rebates work within industry middlemen.
Reality check: The Trump administration has not enacted any major policies on drug prices. Today's executive orders on their own have limited authority and could take a long time to go into effect, if they go into effect at all.
The big picture: A lower drug pricing index and Canadian drug importation have been longstanding initiatives within the Trump administration. Together, all four executive orders would:
- Link Medicare payments to drug prices in foreign countries.
- Lower the price of insulin and Epi-Pens provided at hospitals from a current drug discount program.
- Create a way for Americans to purchase cheaper prescription drugs imported from Canada.
- Give patients the drug rebates that are obtained by pharmacy benefit managers, a proposal that the administration already killed in 2019.
